glp-1 stomach paralysis Lawsuit Filed Against Ozempic, Mounjaro Over 'Stomach Paralysis' Weight Loss Drugs Like Ozempic,
Description
Derived from the proglucagon gene, oxyntomodulin acts as a dual agonist at GLP-1 and glucagon receptors, promoting satiety and increasing energy expenditure (Cohen et al., 2003)
The FDA has made clear that compounded GLP-1 products are not evaluated for safety, efficacy, or quality
Lancet 2024;404(10467):20772093
Not stopping completely
Naltrexone works by blocking opioid receptors that release dopamine and create euphoric effects
Rx Outreach
